Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies

Version 1 : Received: 2 April 2024 / Approved: 2 April 2024 / Online: 2 April 2024 (10:26:09 CEST)

How to cite: Mahmoud, A.M.; Moustafa, A.; Day, C.; Ahmed, M.E.; Zeina, W.; Marzouk, U.M.; Basourakos, S.; Haloi, R.; Mahon, M.; Muniz, M.; Childs, D.S.; Orme, J.J.; Riaz, I.B.; Kendi, A.T.; Stish, B.J.; Davis, B.J.; Kwon, E.D.; Andrews, J.R. Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Preprints 2024, 2024040193. https://doi.org/10.20944/preprints202404.0193.v1 Mahmoud, A.M.; Moustafa, A.; Day, C.; Ahmed, M.E.; Zeina, W.; Marzouk, U.M.; Basourakos, S.; Haloi, R.; Mahon, M.; Muniz, M.; Childs, D.S.; Orme, J.J.; Riaz, I.B.; Kendi, A.T.; Stish, B.J.; Davis, B.J.; Kwon, E.D.; Andrews, J.R. Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Preprints 2024, 2024040193. https://doi.org/10.20944/preprints202404.0193.v1

Abstract

Prostate cancer lung metastasis represents a clinical conundrum due to their implication of advanced disease progression and the complexities they introduce in treatment planning. As the disease progresses to distant sites such as the lung, the clinical management becomes increasingly intricate, requiring tailored therapeutic strategies to address the unique characteristics of metastatic lesions. This review seeks to synthesize the current state of knowledge surrounding prostate cancer metastasis to the lung, shedding light on the diverse array of clinical presentations encountered, ranging from subtle radiological findings to overt symptomatic manifestations. By examining the diagnostic modalities utilized in identifying this metastasis, including advanced imaging techniques and histopathological analyses, the review aims to provide insights into the diagnostic landscape and the challenges associated with accurately characterizing lung metastatic lesions in prostate cancer patients. Moreover, the review delves into the nuances of therapeutic interventions employed in managing prostate cancer lung metastasis, encompassing systemic treatments such as hormonal therapies and chemotherapy, as well as metastasis-directed therapies including surgery and radiotherapy.

Keywords

Prostate Cancer; Lung Metastasis; Systemic Therapy; Metastasis-Directed therapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.